When most people hear about GLP-1 medications such as semaglutide or tirzepatide, they immediately think about weight loss. But weight reduction is only part of the story. Research over the past several years has shown that medications affecting the GLP-1 pathway may...
If you’ve learned about the Medicare GLP-1 Bridge Program and believe you may qualify, your next question is probably: “How do I apply?” The application process can seem confusing, especially with Medicare coverage rules, prior authorization...
If you’ve been following the news about the Medicare GLP-1 Bridge Program, you’re probably asking one question above all others: “Do I qualify?” The answer isn’t always straightforward. Eligibility depends on your Medicare coverage, your...
If you’ve heard about Zepbound® (tirzepatide) and are wondering whether Medicare will help pay for it in 2026, you’re not alone. Millions of older Americans struggle with obesity and its complications, including heart disease, sleep apnea, arthritis, high...
Why Are GLP-1 Medications Helping So Many Different Medical Conditions? For years, GLP-1 medications such as semaglutide (Wegovy®, Ozempic®) and tirzepatide (Zepbound®, Mounjaro®) were viewed primarily as weight-loss or diabetes medications. Today, researchers are...
For many people, GLP-1 medications are known simply as “weight-loss injections.” While weight reduction is certainly an important benefit, research over the last several years has revealed something much more remarkable. Scientists now recognize that GLP-1...
